These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15107183)

  • 1. Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.
    Maddock C; Baita A; Orrù MG; Sitzia R; Costa A; Muntoni E; Farci MG; Carpiniello B; Pariante CM
    J Psychopharmacol; 2004 Mar; 18(1):41-6. PubMed ID: 15107183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
    Udina M; Moreno-España J; Navinés R; Giménez D; Langohr K; Gratacòs M; Capuron L; de la Torre R; Solà R; Martín-Santos R
    Psychoneuroendocrinology; 2013 Sep; 38(9):1803-13. PubMed ID: 23571152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
    Raison CL; Demetrashvili M; Capuron L; Miller AH
    CNS Drugs; 2005; 19(2):105-23. PubMed ID: 15697325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.
    Huckans M; Fuller B; Wheaton V; Jaehnert S; Ellis C; Kolessar M; Kriz D; Anderson JR; Berggren K; Olavarria H; Sasaki AW; Chang M; Flora KD; Loftis JM
    J Psychosom Res; 2015 Feb; 78(2):184-92. PubMed ID: 25219976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of quantitative EEG and mini-mental state examination in interferon-alpha-treated hepatitis C.
    Kamei S; Sakai T; Matsuura M; Tanaka N; Kojima T; Arakawa Y; Matsukawa Y; Mizutani T; Oga K; Ohkubo H; Matsumura H; Hirayanagi K
    Eur Neurol; 2002; 48(2):102-7. PubMed ID: 12187000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C.
    Amodio P; De Toni EN; Cavalletto L; Mapelli D; Bernardinello E; Del Piccolo F; Bergamelli C; Costanzo R; Bergamaschi F; Poma SZ; Chemello L; Gatta A; Perini G
    J Affect Disord; 2005 Jan; 84(1):93-8. PubMed ID: 15620390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
    McNutt MD; Liu S; Manatunga A; Royster EB; Raison CL; Woolwine BJ; Demetrashvili MF; Miller AH; Musselman DL
    Neuropsychopharmacology; 2012 May; 37(6):1444-54. PubMed ID: 22353759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Gender on Interferon-Associated Depression and Anxiety.
    Rempel JD; Krueger C; Uhanova J; Wong S; Minuk GY
    J Interferon Cytokine Res; 2019 Jul; 39(7):416-420. PubMed ID: 31070512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.
    Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1091-9. PubMed ID: 12030950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon-alpha-induced psychiatric side effects in patients with chronic viral hepatitis: a prospective, observational, controlled study].
    Orrù MG; Baita A; Sitzia R; Costa A; Muntoni E; Landau S; Chessa L; Farci MG; Carpiniello B; Pariante CM
    Epidemiol Psichiatr Soc; 2005; 14(3):145-53. PubMed ID: 16255161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
    Schaefer M; Mauss S
    Curr Drug Abuse Rev; 2008 Jun; 1(2):177-87. PubMed ID: 19630716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
    Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
    [No Abstract]   [Full Text] [Related]  

  • 14. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.
    Constant A; Castera L; Dantzer R; Couzigou P; de Ledinghen V; Demotes-Mainard J; Henry C
    J Clin Psychiatry; 2005 Aug; 66(8):1050-7. PubMed ID: 16086622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
    Małyszczak K; Inglot M; Frydecka D; Hadryś T; Pawłowski T
    Adv Clin Exp Med; 2019 Sep; 28(9):1217-1222. PubMed ID: 30811903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
    Mahajan S; Avasthi A; Grover S; Chawla YK
    J Psychosom Res; 2014 Aug; 77(2):109-15. PubMed ID: 25077851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
    Maes M; Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Meltzer H
    Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
    Neri S; Pulvirenti D; Bertino G
    Clin Drug Investig; 2006; 26(11):655-62. PubMed ID: 17163300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.
    Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
    J Clin Psychiatry; 2003 Jun; 64(6):708-14. PubMed ID: 12823087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.